View More Recent Stories

Feb 10, 2021 09:30AM Pre-Open Stock Movers 02/10: (TLRY) (GMDA) (CMLF) Higher; (VNRX) (CPST) (XONE) Lower (more...)
Feb 9, 2021 05:32PM Gamida Cell Ltd. (GMDA) Presents Efficacy and Safety Results of Phase 3 Study of Omidubicel in Patients with Hematologic Malignancies at the 2021 TCT Meetings of ASTCT and CIBMTR
Feb 9, 2021 04:45PM Gamida Cell Presents Efficacy and Safety Results of Phase 3 Study of Omidubicel in Patients with Hematologic Malignancies at the 2021 TCT Meetings of ASTCT and CIBMTR
Jan 11, 2021 03:00PM Gamida Cell to Present Full Data from Phase 3 Study of Omidubicel at TCT, the Combined Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR
Jan 5, 2021 04:01PM Gamida Cell to Present at Upcoming January Investor Conferences
Dec 18, 2020 08:00AM Gamida Cell Added to NASDAQ Biotechnology Index
Dec 14, 2020 07:03AM Gamida Cell (GMDA) Provides Regulatory Update on BLA for Omidubicel
Dec 14, 2020 07:00AM Gamida Cell Provides Regulatory Update on Biologics License Application for Omidubicel
Dec 9, 2020 07:05AM Gamida Cell (GMDA) Provides Pipeline Update, Including Detailed Results of Pivotal Phase 3 Clinical Study of Omidubicel
Dec 9, 2020 07:00AM Gamida Cell Provides Pipeline Update, Including Detailed Results of Pivotal Phase 3 Clinical Study of Omidubicel, and Prepares to Start BLA Submission by End of 2020
Dec 5, 2020 10:30AM Gamida Cell Presents Updated, Expanded Results from Phase 1 Study of Natural Killer Cell Therapy GDA-201 at ASH Annual Meeting and Exposition
Dec 2, 2020 08:01AM Gamida Cell to Host Virtual Pipeline Deep Dive
Nov 24, 2020 08:01AM Gamida Cell to Present at Upcoming Conferences
Nov 10, 2020 08:01AM Gamida Cell Reports Third Quarter 2020 Financial Results and Provides Company Update
Nov 4, 2020 10:30AM Gamida Cell Announces Data to Be Presented at 62nd ASH Annual Virtual Meeting
Nov 4, 2020 08:01AM Gamida Cell to Present at H.C. Wainwright 6th Annual Israel Conference
Nov 2, 2020 08:01AM Gamida Cell Announces the Date of Its Third Quarter 2020 Financial Results and Webcast
Oct 13, 2020 08:01AM Gamida Cell and Be The Match BioTherapies® Expand Strategic Collaboration
Oct 7, 2020 08:01AM Gamida Cell to Present at 2020 Virtual Cell & Gene Meeting on the Mesa
Oct 6, 2020 06:32AM Gamida Cell Ltd. (GMDA) Phase 3 Clinical Study of Omidubicel in Patients with Hematologic Malignancies Met all Three of its Secondary Endpoints
Oct 6, 2020 06:31AM Gamida Cell Announces Positive Topline Data on Secondary Endpoints from Phase 3 Clinical Study of Omidubicel in Patients with Hematologic Malignancies
Sep 10, 2020 09:01AM Gamida Cell Presents Analysis of Observational Data Demonstrating the Impact of Donor Age in Hematopoietic Stem Cell Transplant Outcomes at the Virtual Cord Blood Connect Meeting
Sep 8, 2020 08:01AM Gamida Cell to Participate in Upcoming Investor Conferences
Sep 3, 2020 08:01AM Gamida Cell Announces Two-Part Virtual Miniseries Focused on Omidubicel to Take Place in September
Jan 22, 2019 08:30AM Gamida Cell and Be The Match BioTherapies® Announce Strategic Collaboration
View More Recent Stories